SCHEDULE: Bigger Capital Discloses 9.99% Stake in WORK Medical
Beneficial Ownership Report
Bigger Capital Fund, LP, along with its general partner and managing member, reported a 9.99% beneficial ownership in WORK Medical Technology Group LTD's Class A Ordinary Shares.
Summary
- Bigger Capital Fund, LP, Bigger Capital Fund GP, LLC, and Michael Bigger collectively reported beneficial ownership of 7,897,548 Class A Ordinary Shares of WORK Medical Technology Group LTD.
- This represents approximately 9.99% of the outstanding Class A Ordinary Shares.
- The percentage is based on 79,054,538 Class A Ordinary Shares outstanding immediately after the offering, as per the Issuer's Prospectus Supplement filed on September 26, 2025.
- The reported amount does not include 5,102,230 Class A Ordinary Shares issuable upon exercise of Pre-Funded Warrants, which are subject to a 9.99% beneficial ownership limitation.
- Subsequent to September 25, 2025, the Reporting Persons sold a portion of their Class A Ordinary Shares but continue to beneficially own more than 5.00% of the outstanding shares.
- The filing is a Schedule 13G, indicating a passive investment intent, with a certification that the securities were not acquired for the purpose of changing or influencing control.
Sentiment
Score: 6
Explanation: The filing indicates a significant passive institutional investment in WORK Medical Technology Group LTD, which is generally positive. However, the disclosure of subsequent sales of a portion of shares introduces a slight cautionary note, though the investor still holds over 5%.
Positives
- A significant institutional investor, Bigger Capital, holds a substantial stake, indicating confidence in WORK Medical Technology Group LTD.
Negatives
- Reporting Persons sold a portion of their Class A Ordinary Shares subsequent to the event date, which could be interpreted as a reduction in their position, though they still hold over 5%.
Future Outlook
No forward-looking statements or guidance from WORK Medical Technology Group LTD are provided in this beneficial ownership filing.
Industry Context
This filing indicates an institutional investor's position in a medical technology group. It suggests continued investor interest in the medical technology sector, although specific industry trends or competitive analysis cannot be derived solely from this ownership disclosure.
Stakeholder Impact
- Shareholders: Increased transparency regarding a significant institutional holder; potential impact on stock liquidity and trading patterns due to a large holder.
Key Dates
| Date | Description |
|---|---|
| 09/25/2025 | Date of event requiring the filing of this statement; Bigger Capital beneficially owned 7,897,548 Class A Ordinary Shares. |
| 09/26/2025 | Issuer's Prospectus Supplement filed under Rule 424(b)(5) with the SEC, detailing 79,054,538 Class A Ordinary Shares outstanding after the offering. |
| 09/29/2025 | Date of signing and filing of the Schedule 13G statement. |
Recommendation
holdThe filing indicates a substantial passive investment by Bigger Capital Fund, LP, holding 9.99% of Class A Ordinary Shares. While institutional interest is generally a positive signal, the disclosure of subsequent sales of a portion of these shares after the event date introduces a degree of neutrality. Without further financial or operational details from WORK Medical Technology Group LTD, a 'hold' recommendation is appropriate, acknowledging the institutional backing while awaiting more comprehensive company-specific information.
Keywords
WORK Medical Technology Group LTD, Bigger Capital Fund, Class A Ordinary Shares, Schedule 13G, Beneficial Ownership, Institutional Investor, Medical Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.